Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):962-979. doi: 10.3760/cma.j.issn.1007-3418.2019.12.008.
In order to standardize and update the prevention, diagnosis and antiviral therapy of hepatitis C and to achieve the World Health Organization's goal of eliminating viral hepatitis as a public health threat by 2030, Chinese Medical Association, the Chinese Society of Hepatology, and the Society of Infectious Diseases organized relevant native experts in 2019 to revise the guideline for the prevention and treatment of hepatitis C (2019 version) based on the basic, clinical and prophylactic research progress of hepatitis C infection at home and abroad, combined with the present actual situation of our country, so as to provide an important basis for the prevention, diagnosis and treatment of hepatitis C.
为规范和更新丙型肝炎的预防、诊断及抗病毒治疗,实现世界卫生组织提出的到2030年消除病毒性肝炎作为公共卫生威胁的目标,中华医学会、中华医学会肝病学分会和中华医学会感染病学分会于2019年组织国内相关专家,根据国内外丙型肝炎感染的基础、临床及预防研究进展,并结合我国实际情况,修订了《丙型肝炎防治指南(2019年版)》,为丙型肝炎的预防、诊断和治疗提供重要依据。